Method and kit for synchronous fluorescence detection of hepatitis and HIV virus nucleic acid

A technology of HIV and kits, applied in the direction of microbial-based methods, biochemical equipment and methods, microbial determination/testing, etc., to achieve a wide range of optional effects

Inactive Publication Date: 2013-07-03
SHANGHAI XINGYAO MED TECH DEV CO LTD +1
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0020] The object of the present invention is to provide a kind of test kit that can extract the nucleic acid of HBV, HCV, HIV-1 virus synchronously, detect the nucleic acid of HBV, HCV, HIV-1 virus synchronously in real time, to overcome t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and kit for synchronous fluorescence detection of hepatitis and HIV virus nucleic acid
  • Method and kit for synchronous fluorescence detection of hepatitis and HIV virus nucleic acid
  • Method and kit for synchronous fluorescence detection of hepatitis and HIV virus nucleic acid

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0075] Example 1 Preparation of biotin modified capture probe and negative and positive control 1 Construction of biotin modified universal hybrid capture probe:

[0076] Entrust Shenggong Bioengineering (Shanghai) Co., Ltd. to synthesize the following sequence:

[0077]

[0078] 5′-ACC ACC AAA TGC CCC TAT TTT TTT AGT ACC ACA AGG CCT TTCG AAA AAA CTA TGT TTC CCC TTG GTT CTC TC AAA AAA AAA AAA AAAAAA AAA AAA-3′ and

[0079]

[0080] 5′-Biotin-Oligo(dT) 25 .

[0081] 2 Construction of positive control:

[0082] Entrust Shenggong Bioengineering (Shanghai) Co., Ltd. to synthesize the following sequence:

[0083] HBV DNA positive control sequence:

[0084]

[0085] 5′-CGA CGA GGC AGG ACC CCT AGA AGA AAA AAA AAA AAA AAAAAA AAA AAA-3′;

[0086] HCV RNA positive control sequence:

[0087]

[0088] 5′-CUG CGG AAC CGG UGA GUA CAC AAA AAA AAA AAA AAA AAAAAA AAA-3′;

[0089] HIV-1 RNA positive control sequence:

[0090]

[0091] 5'-CCA UCA AUG AGG AAG CUG CAG AAU GGG AUA AAA AAA AAAAAA AAA AAA AAA AAA-3'...

Example Embodiment

[0096] Example 2 Specimen processing: magnetic bead method for nucleic acid extraction and reagent preparation

[0097] 1 Composition of specimen processing reagents based on the principle of nucleic acid hybridization:

[0098] Lysis solution: 5M guanidine isothiocyanate, 50mM Tris, PH8.0, 10% NP-40, 10% Triton X-100, 6% SDS, 1μM capture probe, 5% polymer, etc.; the capture probe pair HBV is , For HCV , For HIV-1 .

[0099] Magnetic bead suspension: 1mg / mL streptavidin-coated magnetic beads, containing preservatives and dispersing agents such as Tween20;

[0100] Washing liquid W1: LiCl, Tris pH7.0, lithium dodecyl sulfonate, preservatives and dispersants such as Tween20, pigments such as magenta or other fuels;

[0101] Washing liquid W2: LiCl, Tris pH7.0, preservative and dispersant such as Tween20;

[0102] De-inhibitor: alcohol solution containing protease and glycerin;

[0103] Eluent: Tris buffer prepared from DEPC-treated purified water, with Tween 20 dispersant and EDTA, NaN ...

Example Embodiment

[0108] Example 3 Nucleic acid detection: fluorescence complementary hybridization probe detection system model and reagent preparation

[0109] 1 Preparation of fluorescent complementary probe hybridization reaction solution:

[0110] 2×Annealing Buffer: Annealing buffer contains 30mM Tris·HCl (pH8.4), 50mM KCl, 2mM MgCl 2 , 5mM DTT and 1.5% formamide;

[0111] Fluorescent probe mixture: Contains 5μM HBV, HCV, HIV-1 and internal standard fluorescent complementary probe, stabilizer and buffer. For each pair of complementary fluorescently labeled probes, the amount of FAM probes is slightly more than that of non-FAM probes; the 4 pairs of probes are mixed with equal concentrations and equal volumes to make a probe mixture. The concentration of each probe is about It is 5μM.

[0112] Reagent ratio and preparation: mix 2×Annealing Buffer and fluorescent probe mixture at a ratio of 25μL:5μL, and add 20μL nucleic acid sample, the volume of the reaction solution is 50μL, and perform fluores...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Belonging to the technical field of nucleic acid diagnosis, the invention particularly relates to a method and a kit for synchronous extraction and synchronous detection of hepatitis and HIV virus by fluorescent complementary probe hybridization. With a magnetic bead as an automation medium, the method includes a technique for specific synchronous capture of HBV, HCV, and HIV-1 nucleic acids through biotin and oligonucleotide modified capture probes and a Taqman probe-based fluorescent complementary probe hybridization technique for real-time synchronous detections. The corresponding kit includes a disinhibition agent, a lysate, a magnetic bead suspension, a washing liquid, an eluent, an internal control, a 2 * Annealing Buffer, fluorescent probes, a positive control, and a negative control. The method and the kit provided in the invention have the characteristics of: no need of PCR reaction, single tube operation, closed detection, high degree of automation, synchronous extraction of various virus nucleic acids, and synchronous real-time detection, high sensitivity, good specificity and high precision, thus being suitable for large-scale blood screening, clinical examination and scientific research units.

Description

technical field [0001] The invention belongs to the technical field of diagnostic reagents—nucleic acid diagnosis, in particular to a highly sensitive, specific and suitable for synchronous extraction and synchronous real-time detection of hepatitis (including hepatitis B and hepatitis C) and AIDS in routine blood nucleic acid screening Methods and kits for viral nucleic acids. Background technique [0002] According to the statistics of the World Health Organization (WHO), more than half of the countries do not conduct thorough testing on the blood donated by blood donors, resulting in the spread of diseases such as AIDS, hepatitis, malaria and syphilis in many places. Of the 5.6 million HIV-infected people who increase globally every year, 5% to 10% of them are infected through blood transfusion or blood products. The proportion of virus carriers in African children and women is as high as 20% to 25%. Since the 1980s, countries such as France, Japan, Romania, the United ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/70C12Q1/68C12R1/93
Inventor 迟大利吴大治夏懿
Owner SHANGHAI XINGYAO MED TECH DEV CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap